Parvovirus B19 VLP recognizes globoside in supported lipid bilayers

Virology

Volumn 456-457, Issue 1, 2014, Pages 364-369

  Nasir, Waqas ^a   Nilsson, Jonas ^a   Olofsson, Sigvard ^a   Bally, Marta ^b,c   Rydell, Gustaf E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c CNRS   (France)

Author keywords

Carbohydrate; Glycan; Glycobiology; Glycosphingolipids; Parvovirus B19 virus like particles

Indexed keywords

FORSSMAN ANTIGEN; GLOBOSIDE; VIRUS RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN PARVOVIRUS B19; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS LIKE AGENT;

CARBOHYDRATE; GLYCAN; GLYCOBIOLOGY; GLYCOSPHINGOLIPIDS; PARVOVIRUS B19 VIRUS-LIKE PARTICLES;

CAPSID PROTEINS; GLOBOSIDES; LIPID BILAYERS; PARVOVIRUS B19, HUMAN; RECEPTORS, VIRUS; VIROSOMES; VIRUS ATTACHMENT;

EID: 84900431103     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.004     Document Type: Article

References (43)

1. Bally M., Gunnarsson A., Svensson L., Larson G., Zhdanov V., Höök F. Interaction of single viruslike particles with vesicles containing glycosphingolipids. Phys. Rev. Lett. 2011, 107:188103.
2. Bally M., Rydell G.E., Zahn R., Nasir W., Eggeling C., Breimer M.E., Svensson L., Höök F., Larson G. Norovirus GII.4 virus-like particles recognize galactosylceramides in domains of planar supported lipid bilayers. Angew. Chem. Int. Ed. 2012, 51:12020-12024.
3. Bernardi A., Jiménez-Barbero J., Casnati A., De Castro C., Darbre T., Fieschi F., Finne J., Funken H., Jaeger K.-E., Lahmann M., Lindhorst T.K., Marradi M., Messner P., Molinaro A., Murphy P.V., Nativi C., Oscarson S., Penadés S., Peri F., Pieters R.J., Renaudet O., Reymond J.-L., Richichi B., Rojo J., Sansone F., Schäffer C., Turnbull W.B., Velasco-Torrijos T., Vidal S., Vincent S., Wennekes T., Zuilhof H., Imberty A. Multivalent glycoconjugates as anti-pathogenic agents. Chem. Soc. Rev. 2012, 42:4709-4727.
4. Besenicar M., Macek P., Lakey J.H., Anderluh G. Surface plasmon resonance in protein-membrane interactions. Chem. Phys. Lipids 2006, 141:169-178.
5. Brown K.E., Anderson S.M., Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993, 262:114-117.
6. Brown K.E., Hibbs J.R., Gallinella G., Anderson S.M., Lehman E.D., McCarthy P., Young N.S. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). New Engl. J. Med. 1994, 330:1192-1196.
7. Bönsch C., Kempf C., Ros C. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J. Virol. 2008, 82:11784-11791.
8. Bönsch C., Zuercher C., Lieby P., Kempf C., Ros C. The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization. J. Virol. 2010, 84:11737-11746.
9. Cho N.-J., Frank C.W., Kasemo B., Höök F. Quartz crystal microbalance with dissipation monitoring of supported lipid bilayers on various substrates. Nat. Protoc. 2010, 5:1096-1106.
10. Clausen H., Holmes E., Hakomori S. Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization. J. Biol. Chem. 1986, 261:1380-1387.
11. Cooling L., Koerner T., Naides S. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect. Dis. 1995, 172:1198-1205.
12. Cooper M.A. Advances in membrane receptor screening and analysis. J. Mol. Recognit. 2004, 17:286-315.
13. Dam T.K., Brewer C.F. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Glycobiology 2010, 20:270-279.
14. Eierhoff, T., Stechmann, B., Römer, W., 2012. Pathogen and toxin entry - how pathogens and toxins induce and harness endocytotic mechanisms, in: Ceresa, B. (Ed.), Molecular Regulation of Endocytosis.
15. Erb E.M., Chen X., Allen S., Roberts C.J., Tendler S.J., Davies M.C., Forsén S. Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip. Anal. Biochem. 2000, 280:29-35.
16. Evans S.V., Roger MacKenzie C. Characterization of protein-glycolipid recognition at the membrane bilayer. J. Mol. Recognit. 1999, 12:155-168.
17. Ewers H., Helenius A. Lipid-mediated endocytosis. Cold Spring Harb. Perspect. Biol. 2011, 3:a004721.
18. Ewers H., Romer W., Smith A.E., Bacia K., Dmitrieff S., Chai W., Mancini R., Kartenbeck J., Chambon V., Berland L., Oppenheim A., Schwarzmann G., Feizi T., Schwille P., Sens P., Helenius A., Johannes L. GM1 structure determines SV40-induced membrane invagination and infection. Nat. Cell Biol. 2010, 12:11-12.
19. Florea A.V., Ionescu D.N., Melhem M.F. Parvovirus B19 infection in the immunocompromised host. Arch. Pathol. Lab. Med. 2007, 131:799-804.
20. Gallinella G. Parvovirus B19 achievements and challenges. ISRN Virol. 2013, 2013:1-33.
21. Hansson G.C., Karlsson K.A., Larson G., Stromberg N., Thurin J., Orvell C., Norrby E. A novel approach to the study of glycolipid receptors for viruses. Binding of Sendai virus to thin-layer chromatograms. FEBS Lett. 1984, 170:15-18.
22. Karlsson K., Larson G. Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human Le(a-b+) secretor. J. Biol. Chem. 1981, 256:3512-3524.
23. Kaufmann B., Baxa U., Chipman P.R., Rossmann M.G., Modrow S., Seckler R. Parvovirus B19 does not bind to membrane-associated globoside in vitro. Virology 2005, 332:189-198.
24. Koppisetty C.A., Nasir W., Strino F., Rydell G.E., Larson G., Nyholm P.G. Computational studies on the interaction of ABO-active saccharides with the norovirus VA387 capsid protein can explain experimental binding data. J. Comput. Aided Mol. Des. 2010, 24:423-431.
25. Leisi R., Ruprecht N., Kempf C., Ros C. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism. J. Virol. 2013, 87:13161-13167.
26. Lingwood C.A. Aglycone modulation of glycolipid receptor function. Glycoconj. J. 1996, 13:495-503.
27. Lingwood C.A. Glycosphingolipid functions. Cold Spring Harb. Perspect. Biol. 2011, 3:1-26.
28. Mammen M., Choi S.-K., Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. Engl. 2010, 30:2755-2794.
29. Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J., Kodera T., Ishii T., Hirabayashi Y., Koyanagi Y., Sasaki T. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 2005, 106:3449-3456.
30. Nilsson J., Rydell G.E., Le Pendu J., Larson G. Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids. Glycoconj. J 2009, 26:1171-1180.
31. Nilsson J., Rüetschi U., Halim A., Hesse C., Carlsohn E., Brinkmalm G., Larson G. Enrichment of glycopeptides for glycan structure and attachment site identification. Nat. Methods 2009, 6:809-811.
32. Nyholm P.G., Pascher I. Orientation of the saccharide chains of glycolipids at the membrane surface: conformational analysis of the glucose-ceramide and the glucose-glyceride linkages using molecular mechanics (MM3). Biochemistry 1993, 32:1225-1234.
33. Romer W., Berland L., Chambon V., Gaus K., Windschiegl B., Tenza D., Aly M.R., Fraisier V., Florent J.C., Perrais D., Lamaze C., Raposo G., Steinem C., Sens P., Bassereau P., Johannes L. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 2007, 450:670-675.
34. Rydell G.E., Dahlin A.B., Hook F., Larson G. QCM-D studies of human norovirus VLPs binding to glycosphingolipids in supported lipid bilayers reveal strain-specific characteristics. Glycobiology 2009, 19:1176-1184.
35. Rydell G.E., Svensson L., Larson G., Johannes L., Römer W. Human GII.4 norovirus VLP induces membrane invaginations on giant unilamellar vesicles containing secretor gene dependent α1,2-fucosylated glycosphingolipids. Biochim. Biophys. Acta - Biomembr. 2013, 1828:1840-1845.
36. Sens P., Johannes L., Bassereau P. Biophysical approaches to protein-induced membrane deformations in trafficking. Curr. Opin. Cell Biol. 2008, 20:476-482.
37. Servant-Delmas A., Lefrère J.-J., Morinet F., Pillet S. Advances in human B19 erythrovirus biology. J. Virol. 2010, 84:9658-9665.
38. Servey J.T., Reamy B.V., Hodge J. Clinical presentations of parvovirus B19 infection. Am. Fam. Physician 2007, 75:373-376.
39. Svensson L., Hult A.K., Stamps R., Ångström J., Teneberg S., Storry J.R., Jørgensen R., Rydberg L., Henry S.M., Olsson M.L. Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system. Blood 2013, 121:1459-1468.
40. Weigel-Kelley K.A., Yoder M.C., Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003, 102:3927-3933.
41. Yaegashi N., Niinuma T., Chisaka H., Watanabe T., Uehara S., Okamura K., Moffatt S., Sugamura K., Yajima A. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J. Infect. 1998, 37:28-35.
42. Yamamoto M., Cid E., Yamamoto F. Molecular genetic basis of the human Forssman glycolipid antigen negativity. Sci. Rep. 2012, 2:975.
43. Yang Z., Bergström J., Karlsson K.A. Glycoproteins with Gal alpha 4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities. J. Biol. Chem. 1994, 269:14620-14624.